drugset / Trial / NCT00211484

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

NCT00211484

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A compassionate method of treatment is offered to patients where lesions do not meet acceptable criteria for standard therapy. Visudyne (Photodynamic Therapy) and laser photocoagulation treatment (a treatment using heat from a fine point laser beam) have not been found to be effective in treating the lesions these patients have. Anecortave acetate is an experimental drug that is being tested to prevent the growth of blood vessels under the retina in patients with age-related macular degeneration (AMD).

Timeline

Start
2003-05
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Anecortave Acetate Small molecule 15 mg Other